Literature DB >> 12199660

Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

David L B Schwappach1.   

Abstract

Most health economists agree that public preferences should play a major role in setting criteria for distributing scarce resources. The quality-adjusted life year (QALY) is used as a preference-based measure for the outcome of health-care activities in health economic evaluative studies. Traditionally, health economists proposed maximizing the additional health gain in terms of QALYs so as to maximize social welfare. Evidence has grown however, that neither potential health gain as a single relevant determinant of value, nor the rule of maximizing this health gain are sufficient. Concerns about fairness and equity are also important to the public in distributional decisions. This paper reviews the debate on the role and limitations of the QALY in health-care priority setting and the empirical evidence surrounding it. A framework is used to systematically explore the available data on factors considered to be important to the public in health-care resource allocation, and to investigate how these fit with the implicit value judgements inherent in the original QALY formulation. Potential sources of social value are classified into (1) factors that relate to the characteristics of patients and (2) factors related to the characteristics of the intervention's effect on patients' health. As well as these main categories, the article considers preferences for distributional rules. Recent approaches that aim to capture public preferences more comprehensively and to better reflect the value attributed to different health-care programmes in economic evaluation methods are outlined briefly.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2002        PMID: 12199660      PMCID: PMC5060157          DOI: 10.1046/j.1369-6513.2002.00182.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  62 in total

Review 1.  The value of DALY life: problems with ethics and validity of disability adjusted life years.

Authors:  T Arnesen; E Nord
Journal:  BMJ       Date:  1999-11-27

2.  Public preferences for the allocation of donor liver grafts for transplantation.

Authors:  J Ratcliffe
Journal:  Health Econ       Date:  2000-03       Impact factor: 3.046

3.  Principles of justice in health care rationing.

Authors:  R Cookson; P Dolan
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

4.  Is the valuation of a QALY gained independent of age? Some empirical evidence.

Authors:  M Johannesson; P O Johansson
Journal:  J Health Econ       Date:  1997-10       Impact factor: 3.883

5.  A note on prevention versus cure.

Authors:  M Johannesson; P O Johansson
Journal:  Health Policy       Date:  1997-09       Impact factor: 2.980

6.  A note on the estimation of the equity-efficiency trade-off for QALYs.

Authors:  M Johannesson; U Gerdtham
Journal:  J Health Econ       Date:  1996-06       Impact factor: 3.883

7.  Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1989 Apr-Jun       Impact factor: 2.583

8.  Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments.

Authors:  D G Fryback; W F Lawrence
Journal:  Med Decis Making       Date:  1997 Jul-Sep       Impact factor: 2.583

9.  Time in health: can we measure individuals' "pure time preferences"?

Authors:  A Gafni
Journal:  Med Decis Making       Date:  1995 Jan-Mar       Impact factor: 2.583

10.  Persons vs years: two ways of eliciting implicit weights.

Authors:  J A Olsen
Journal:  Health Econ       Date:  1994 Jan-Feb       Impact factor: 3.046

View more
  35 in total

Review 1.  Glutaric aciduria type 1 and neonatal screening: time to proceed--with caution.

Authors:  Andrea Superti-Furga
Journal:  Eur J Pediatr       Date:  2003-10-25       Impact factor: 3.183

Review 2.  Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives.

Authors:  A Simon Pickard; Sara J Knight
Journal:  Med Care       Date:  2005-05       Impact factor: 2.983

3.  Choosing vs. allocating: discrete choice experiments and constant-sum paired comparisons for the elicitation of societal preferences.

Authors:  Chris D Skedgel; Allan J Wailoo; Ron L Akehurst
Journal:  Health Expect       Date:  2013-06-12       Impact factor: 3.377

Review 4.  Societal values in the allocation of healthcare resources: is it all about the health gain?

Authors:  Tania Stafinski; Devidas Menon; Deborah Marshall; Timothy Caulfield
Journal:  Patient       Date:  2011       Impact factor: 3.883

5.  Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expected.

Authors:  Allan Wailoo; Aki Tsuchiya; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Are some QALYs more equal than others?

Authors:  E J van de Wetering; N J A van Exel; J M Rose; R J Hoefman; W B F Brouwer
Journal:  Eur J Health Econ       Date:  2014-12-06

7.  Who prefers the 'cost-effectiveness ratio' prioritization approach in health-care decisions? Results of an empirical analysis.

Authors:  Kathrin Damm; Anne Prenzler; Andy Zuchandke
Journal:  Health Expect       Date:  2014-06-06       Impact factor: 3.377

8.  Israeli lay persons' views on priority-setting criteria for Alzheimer's disease.

Authors:  Perla Werner
Journal:  Health Expect       Date:  2009-03-23       Impact factor: 3.377

Review 9.  A systematic review of stated preference studies reporting public preferences for healthcare priority setting.

Authors:  Jennifer A Whitty; Emily Lancsar; Kylie Rixon; Xanthe Golenko; Julie Ratcliffe
Journal:  Patient       Date:  2014       Impact factor: 3.883

10.  A cost-based equity weight for use in the economic evaluation of primary health care interventions: case study of the Australian Indigenous population.

Authors:  Katherine S Ong; Margaret Kelaher; Ian Anderson; Rob Carter
Journal:  Int J Equity Health       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.